Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. Engel SS, Suryawanshi S, Stevens SR, Josse RG, Cornel JH, Jakuboniene N, Riefflin A, Tankova T, Wainstein J, Peterson ED, Holman RR; TECOS Study Group. Diabetes Obes Metab. 2017 Nov;19(11):1587-1593. doi: 10.1111/dom.12983. Epub 2017 Jul 7. PMID: 28432745 Clinical Trial.

  • Erin Morton (Other)

Activity: Other activity typesOther